<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00417768</url>
  </required_header>
  <id_info>
    <org_study_id>05-0238-E</org_study_id>
    <nct_id>NCT00417768</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness of tPA in Intra-abdominal Abscesses</brief_title>
  <official_title>Safety and Effectiveness of Local Instillation of tPA in the Management of Complex Intra-abdominal Fluid Collections: a Randomized, Double Blinded Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine if instillation of tissue plasminogen activator into a percutaneously drained
      intra-abdominal abscess cavity results in faster resolution of the abscess compared to normal
      standard of care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      On day 0 Subjects will have Tissue Plasminogen Activator injected into a drainage tube and
      allowed to dwell in the intra-abdominal abscess for one hour before allowing it to drain by
      gravity. This will be repeated on day 1 and 2.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Change in patient population no longer fit study criteria.
  </why_stopped>
  <start_date>July 2005</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time to eating</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>time to discharge</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>radiological evidence of resolution</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>cost comparison</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Abscess</condition>
  <arm_group>
    <arm_group_label>Tissue Plasminogen Activator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>tPA administered by drainage tube into abscess, allowed to dwell for one hour and then drained into drainage bag. Dose of tPA administered to be determined by the volume of drainage immediately post drain insertion. This intervention is done on day 0, 1 and 2.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Instillation of Normal Saline</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Insertion of abdominal drainage tube to drain intra-abdominal abscess. Normal Saline administered immediately post drain insertion. Normal Saline (10 cc) allowed to dwell for one hour, then allowed to drain into drainage bag.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tissue Plasminogen Activator</intervention_name>
    <description>The dosage of tPA is determined by the volume of drainage obtained when abscess is first drained. The same dose will be repeated on day 1 and 2.</description>
    <arm_group_label>Tissue Plasminogen Activator</arm_group_label>
    <other_name>Intra-abdominal drainage</other_name>
    <other_name>tPA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <description>Normal Saline will be used rather than Tissue Plasminogen Activator for the Sham arm.</description>
    <arm_group_label>Instillation of Normal Saline</arm_group_label>
    <other_name>Intra-abdominal abscess drain</other_name>
    <other_name>sham arm</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Intrabdominal abscess

        Exclusion Criteria:

          -  Hypersensitivity to tPA

          -  Recent stroke

          -  Uncontrolled htn

          -  Recent major hemorrhage

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dheeraj Rajan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Health Network - University of Toronto</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Murray Asch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lakeridge Health Science Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Health Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 2, 2007</study_first_submitted>
  <study_first_submitted_qc>January 3, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 4, 2007</study_first_posted>
  <last_update_submitted>January 13, 2014</last_update_submitted>
  <last_update_submitted_qc>January 13, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tissue plasminogen activator</keyword>
  <keyword>intraabdominal</keyword>
  <keyword>abscess</keyword>
  <keyword>percutaneous drainage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abscess</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Plasminogen</mesh_term>
    <mesh_term>Tissue Plasminogen Activator</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

